Literature DB >> 30787057

Therapeutic Inertia and the Legacy of Dysglycemia on the Microvascular and Macrovascular Complications of Diabetes.

Kamlesh Khunti1, Samuel Seidu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30787057     DOI： 10.2337/dci18-0030

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

Review 1.  The efficacy and safety of oral semaglutide for glycaemic management in adults with type 2 diabetes compared to subcutaneous semaglutide, placebo, and other GLP-1 RA comparators: A systematic review and network meta-analysis.

Authors:  Yousef Alhindi; Amanda Avery
Journal:  Contemp Clin Trials Commun       Date:  2022-06-24

Review 2.  Type 2 diabetes mellitus in older adults: clinical considerations and management.

Authors:  Srikanth Bellary; Ioannis Kyrou; James E Brown; Clifford J Bailey
Journal:  Nat Rev Endocrinol       Date:  2021-06-25       Impact factor: 43.330

Review 3.  Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy.

Authors:  Mouhamed Nashawi; Mahmoud S Ahmed; Toka Amin; Mujahed Abualfoul; Robert Chilton
Journal:  World J Cardiol       Date:  2021-12-26

Review 4.  Adjuvant Therapy With Mushroom Polysaccharides for Diabetic Complications.

Authors:  Xue Jiang; Weiqi Meng; Lanzhou Li; Zhaoli Meng; Di Wang
Journal:  Front Pharmacol       Date:  2020-02-28       Impact factor: 5.810

Review 5.  Management of type 2 diabetes: consensus of diabetes organizations.

Authors:  Elaena Quattrocchi; Tamara Goldberg; Nino Marzella
Journal:  Drugs Context       Date:  2020-01-27

6.  Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database.

Authors:  Corinne Emery; Elodie Torreton; Sylvie Dejager; Laurie Levy-Bachelot; Sébastien Bineau; Bruno Detournay
Journal:  Diabetes Ther       Date:  2020-01-17       Impact factor: 2.945
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.